Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma

Ruttenberg Treatment Center - Mount Sinai, New York

Stony Brook University - Long Island Cancer Center, Stony Brook

USOR Oncology Network- New York Oncology, New York

Roswell Park Comprehensive Cancer Center, Buffalo

University of Maryland - Marlene and Stewart Greenebaum Cancer Center, Baltimore

USO Oncology Network-Oncology and Hematology Associates of Southwest Virginia, Inc., Roanoke

Medical College of South Carolina, Charleston

Mount Sinai Medical Center, Miami Beach

Sarah Cannon Research Institute at Tennessee Oncology, Nashville

The University of Tennessee Medical Center, Knoxville

University Hospitals Seidman Cancer Center, Cleveland

University of Cincinnati Cancer Institute, Cincinnati

University of Michigan Comprehensive Cancer Center, Ann Arbor

Henry Ford Health Center, Detroit

Medical College of Wisconsin, Milwaukee

University of Wisconsin School of Medicine and Public Health, Madison

Mayo Clinic, Rochester

Methodist Dallas Medical Center, Dallas

Parkland Health & Hospital System, Dallas

University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas

Houston Methodist Hospital - Outpatient Center, Houston

UT MD Anderson Cancer Center, Houston

Comprehensive Cancer Center of Nevada, Las Vegas

University of California, Los Angeles, School of Medicine, Santa Monica

City of Hope, Duarte

USO Oncology Network-Northwest Cancer Specialists, P.C., Portland

Providence Cancer Center, Anchorage

USO Oncology Network- Rocky Mountain Cancer Centers, Denver

University of Chicago Medical Center - Duchossis Center for Advanced Medicine, Chicago

Summit Medical Group - Florham Park Campus, Florham Park

USO Oncology Network-Texas Oncology, Tyler

USO Oncology Network-Virginia Oncology Associates - Brock Cancer Center - Norfolk, Norfolk